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Abstract
OBJECTIVES: Macrophages (M) are one of the most important cells of the innate immune system for ﬁrst line defense. Upon transplant-
ation (Tx), M play a prominent role during lung ischaemia reperfusion (I/R) injury. Here, we hypothesize that the depletion of donor M
ameliorates the post-transplant lung I/R injury.
METHODS: Orthotopic single-lung Tx was performed between syngeneic BALB/c mice after a cold ischaemic time of 8 h and a reperfusion
time of 10 h. Prior to graft implantation, alveolar macrophages of donor lungs were selectively depleted applying the ‘suicide technique’
by intratracheal application of clodronate liposomes (experimental, n = 6) vs the application of empty liposomes (control, n = 6). Cell count
(number of F4/80+-macrophages) and graft injury were evaluated by histology and immunohistochemistry, and levels of lactat dehydro-
genase (LDH) (apoptosis assay), enzyme linked immunosorbent assay for nuclear protein high-mobility-group-protein B1 (HMGB1),
tumor necrosis factor alpha (TNF-α) and transforming growth factor beta1 (TGF–β1) in plasma were analysed.
RESULTS: Clodronate liposomes successfully reduced 70% of M from donor lungs when compared with grafts treated with empty lipo-
some only. M-depleted transplants showed improved histology and revealed considerably less graft damage when compared with control
recipients (LDH, P = 0.03; HMGB1, P = 0.3). Oxygenation capacity was ameliorated in M-depleted transplants, if not signiﬁcant (P = 0.114);
however, wet/dry ratio did not differ between groups (P = 0.629). The inﬂammatory response was signiﬁcantly reduced in M-depleted
mice when compared with control recipients (TNF-α, P = 0.042; TGF-β1, P = 0.039).
CONCLUSIONS: The selective depletion of M in donor lung transplants can be successfully performed and results in a sustained anti-
inﬂammatory response upon I/R-injury. The beneﬁcial effect of this preconditioning method should be further evaluated as a promising
tool for the attenuation of I/R prior to graft implantation in clinical Tx.
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INTRODUCTION
Ischaemia-reperfusion (I/R) injury inevitably occurs after lung
transplantation (Tx) and results in hypoxaemia, pulmonary oedema
and alveolar cell damage within the ﬁrst 72 h of lung Tx. This in-
ﬂammatory process has been shown to show a biphasic response
primarily initiated by resident macrophages (M) from the donor
lung, and later be dominated by inﬁltrating neutrophil cells. M
belong to the most important immune cells for ﬁrst line defense
during early I/R injury [1, 2]. These cells are a major source of a wide
variety of biologically active substances, including cytokines,
chemokines but also growth factors. Once activated, they release
these mediators in response to I/R-induced oxidative stress. For
example, tumor necrosis factor alpha (TNF-α), released by M, has
been shown to be an essential component in the cascade of inﬂam-
matory events causing lung I/R injury, not only in animal experi-
ments [3, 4] but also in human studies [5]. When blocking TNF-α [3],
using TNF-α k.o. mice [6], I/R damage could be signiﬁcantly abol-
ished. Given the presence and ability of cytokine and chemokine
production by M, several M-depletion studies have been con-
ducted with the aim of diminishing the detrimental effects of
M. Indeed, it could be shown in ischaemia models that the deple-
tion of M is protective against injury and that they are key players in
the course of I/R injury development [7, 8].
However, also anti-inﬂammatory effects have been assigned to
M. Recently, M were differentiated into various distinct functional
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subtypes with a different activation and polarization status. Classically
activated M (M1) are activated by type 1 cytokines including inter-
feron gamma and the subsequent promotion of a Th1 response. In
contrast, alternatively activated M (M2) were shown to ameliorate
type 1 inﬂammatory responses and modulate type 2 immune
responses, angiogenesis and tissue repair, thereby promoting a rather
protective effect to an inﬂammatory state.
Here, we tested in the in vivo model of mouse lung Tx whether
the depletion of donor M has a beneﬁcial effect on I/R injury. Unlike
previously employed murine models of I/R-injury, the Tx model
used here has the advantage of being able to mimic the physiologic-
al clinical condition thus making it a highly clinically relevant re-
search model of I/R-injury in which all, ventilation and perfusion as
well as cold ischaemia is applied to the engrafted organ.
MATERIALS ANDMETHODS
Animals, study design and mouse lung Tx model
Speciﬁc pathogen-free inbred male BALB/c mice (Harlan, Horst,
Netherlands), weighing 25–32 g, were used. Animals received ad-
equate care in strict accordance with The Principles of Laboratory
Animal Care (National Institutes of Health publication no. 85-23,
promulgated in 1985, most recently revised in 1996). The study
was approved by the local veterinary ethical committee (approval
number 2/2010).
Orthotopic, single-lung Tx was performed as we described [9].
Mice were orotracheally intubated with a 20-G intravenous cath-
eter (BD Insyte, Becton Dickinson S.A., Madrid, Spain) and con-
nected to a pressure-controlled ventilator (UNO Respirator,
Amsterdam, Netherlands). Analgesia was carried out using bupre-
norphine 0.1 mg/kg, given 30 min prior to the thoracic surgical in-
cision as well as 30 min before closure of the thorax and 6 h after
the Tx procedure. The lungs were ventilated at a respiratory rate of
150 breaths/min and anaesthesia was maintained by ventilation
with a positive end-expiratory pressure of 0.05 kPa and a tidal
volume of 0.5 ml (animals weighing 25–27 g) and 1.0 ml (animals
weighing 28–30 g) of 99.5% humidiﬁed, warmed oxygen with a
fraction of 0.5% isoﬂurane (Attane; Minrad I, Buffalo, NY, USA). A
heart rate of 280 beats/min was maintained to assure stable cir-
culation and subsequent perfusion of preserving solution through-
out the pulmonary parenchyma.
The donor graft was exposed to 8 h cold ischaemia time before
Tx. Grafts were analysed 3 or/and 10 h after Tx.
Macrophage depletion by clodronate liposomes
Alveolar macrophages of donor lungs were depleted by applying
the ‘suicide technique’ through intratracheal application of lipo-
somes. Liposomes were prepared as previously reported [10].
Liposomally encapsulated clodronate (18 mg/ml clodronate) or
control empty liposomewere stored at −80°C and thawed immedi-
ately prior to use. Both clodronate (1 mg/ml) and empty liposomes
were prepared in 50 μl volume for intratracheal application. After
intubation of donor mice, liposomes were applied via the intratra-
cheally placed tube, followed by regular ventilation as described
above. For equal distribution of the clodronate liposomes, inter-
mittent increase in the positive end-expiratoy pressure (10 times)
was applied. The efﬁciency of clodronate liposomes was evaluated
by F4/80+ immunohistochemistry.
Histology and immunohistochemistry for F4/80+ cells
Parafﬁn-embedded tissue sections were rehydrated and incu-
bated with rat monoclonal anti mouse F4/80 antibody (BMA bio-
medicals, Augst, Switzerland). We followed the manufacturer’s
instruction for blocking of non-speciﬁc binding and antigen re-
trieval (proteinase K). Primary and secondary antibody (horserad-
ish peroxidase) bindings were visualized by 3,30-diaminobenzidine.
Graft function
Before retrieval of the transplanted organ, mice were orotrache-
ally intubated, connected to the pressure-controlled ventilator as
described above and a laparosternotomy was performed. Graft
oxygenation was evaluated by sampling blood (200 µl) directly
from the left ventricle through a heparinized needle.
Wet/dry weight ratio
This assay reﬂects the extent of post-reperfusion pulmonary
oedema. To do so, the transplanted lung was harvested, weighed
and then placed in an oven at 180°C for 2 h. After the drying pro-
cedure, the transplant was weighed again, and the weight ratio
before and after drying was calculated.
Tissue necrosis assay for lactat dehydrogenase
Circulating lactat dehydrogenase (LDH) was measured in hepari-
nized mouse plasma taken from the recipient at the time of sacri-
ﬁce by DRI-CHEM 400i (FUJIFILM, Tokyo, Japan).
Enzyme linked immunosorbent assay for high-
mobility-group-protein B1, TNF-α and
transforming growth factor beta1
Heparinized mouse plasma taken from the recipient at the
time of sacriﬁce was used for high-mobility-group-protein B1
(HMGB1) (IBL international, Hamburg, Germany), TNF-α (Duo Set,
R&D Systems, Minneapolis, MN, USA) and transforming growth
factor beta1 (TGF-β1) (Duo Set, R&D Systems) enzyme linked im-
munosorbent assay. Experimental procedures were followed by
the manufacturer’s instructions.
Statistical analysis
Data were presented as means ± SD. Groups were compared with
the Student t-test for unpaired samples using Prism 4.0 (GraphPad
Software, San Diego, CA, USA). A two-sided P-value of <0.05 was
considered statistically signiﬁcant.
RESULTS
Table 1 summarizes the principal results obtained frommacrophage-
depleted (clodronate) transplants, and control transplants 10 h after
reperfusion (Table 1).
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Donor lung macrophages are successfully depleted
by clodronate liposomes
F4/80+ stained macrophages were successfully depleted by clo-
dronate liposomes at 10 h of reperfusion after a cold ischaemic
time of 8 h (Fig. 1). The success rate was 70%, which corresponds
to previously reported rates of M depletion [11].
Graft histology is improved upon macrophage
depletion
H&E staining of lung sections from the clodronate liposome
treated Tx group showed mildly less oedema, less thickening of
the alveolar wall and less graft inﬁltrating leucocytes, when com-
pared with the control Tx group (Fig. 2). Of note, these inﬁltrating
cells were distinct from macrophages.
Transplant oxygenation mildly improve upon
macrophage depletion
Ten hours after graft reperfusion, oxygenation slightly improved in
transplanted grafts which were macrophage-depleted when com-
pared with the control group (Fig. 3). However, this was not
signiﬁcant (control: 317.9 ± 69.6 vs clodronate: 452.7 ± 64.8
mmHg, P = 0.114).
Graft oedema is not reduced upon macrophage
depletion
The wet/dry ratios from transplanted grafts that were retrieved 10 h
after reperfusion did not differ between the two groups (Fig. 4)
(control: 6.78 ± 0.14 vs clodronate: 6.87 ± 0.29, P = 0.629).
Cell injury is reduced upon macrophage depletion
I/R injury was analysed after 8 h of cold storage and 10 h of reper-
fusion assessing circulating LDH and HMGB1 levels released from
damaged cells. The release of the cytoplasmic enzyme LDH and
the nuclear protein HMGB1 indicates an increased level of tissue
damage which reﬂects necrosis. In line with the histological picture
(Fig. 2), macrophage ablation with clodronate resulted in a signiﬁ-
cant reduction of tissue damage, which is reﬂected by less circulat-
ing LDH and HMGB1 levels in recipient mice (Fig. 5), (LDH control:
439 ± 99 vs clodronate: 164 ± 7 U/l, P = 0.03; and HMGB1 control:
7.2 ± 2.5 vs clodronate: 3.2 ± 1.2 ng/ml, P = 0.3 respectively).
Figure 1: Clodronate liposome treatment signiﬁcantly depletes alveolar macrophages from donor lungs. F4/80+ immune staining shows empty liposome (control: A
and C). The clodronate-treated lung bears more macrophages than the control-treated lung (clodronate: B and C) 10 h after reperfusion (magniﬁcation: ×200).
Table 1: Principal results on measured parameters in macrophage-depleted (clodronate) transplants and control transplants
Parameter Method Results (10 h after Tx)
M—depleted Tx lung Control Tx lung P-value
M content F4/80+ staining 30% 100%
Lung architecture Histology (H&E) Less oedema Increased oedema
Less leucocytes Thickened alveolar wall
O2 saturation (mmHg) Tx oxygenation 452.7 ± 64.8 317.9 ± 69.6 0.114
Lung oedema Wet/Dry ratio 6.87 ± 0.29 6.78 ± 0.14 0.629
LDH (plasma, U/L) DRI-CHEM 400i 164 ± 7 439 ± 99 0.03*
HGMB1 (plasma, ng/ml) ELISA 3.2 ± 1.2 7.2 ± 2.5 0.3
TNF-α (plasma, pg/µl) ELISA 7.59 ± 1.79 14.45 ± 2.1 0.042*
TGF-β1 (plasma, pg/µl) ELISA 1683.57 ± 251 3625.13 ± 458 0.039*
*Indicates significance.
M: macrophage; Tx: transplantation.
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TNF-α is reduced by macrophage depletion
at late reperfusion
Proinﬂammatory cytokine production is a key mechanism of tissue
damage after ischaemic insult. We were analysing the kinetic expres-
sion of the proinﬂammatory cytokine TNF-α in the plasma of recipi-
ents at 3 and 10 h upon reperfusion. The levels of circulating TNF-α
were increasing by 10 h of reperfusion in the control group. In con-
trast, clodronate treatment group showed declining levels of TNF-α
in the circulation at 10 h of reperfusion (Fig. 6), (TNF-α: control
14.45 ± 2.1 vs clodronate 7.59 ± 1.79 pg/µl, P = 0.042). These data are
consistent with our data gained in LDH-associated organ injury.
Figure 2: Graft histology is improved upon macrophage depletion. Ten hours after Tx, the reperfusion resulted in mild oedema, thickening of the alveolar wall and
leucocyte inﬂux into the parenchyma in empty liposome-treated mouse lung (control: A). In comparison, only slight changes were present in the clodronate-treated
lung (B) (H&E staining, magniﬁcation: ×200).
Figure 3: Graft oxygenation in control transplants vs macrophage-depleted
transplants (clodronate), 10 h after reperfusion (control: 317.9 ± 69.6 vs clodro-
nate: 452.7 ± 64.8 mmHg, P = 0.114). Values are expressed as mean ± SD. Figure 4: Wet/dry ratio in control transplants vs macrophage-depleted trans-
plants (clodronate), 10 h after reperfusion (control: 6.78 ± 0.14 vs clodronate:
6.87 ± 0.29, P = 0.629). Values are expressed as mean ± SD.
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TGF-β1 is reduced by macrophage depletion
at late reperfusion
Besides its role in immune homeostasis, TGF-β1 is recognized as a
mediator of acute and also chronic lung injury though enhancement
of alveolar epithelial permeability and the stimulation of the extra
cellular matrix. In line with the increase in LDH and TNF-α, TGF-β1
levels increased in the circulation at 3 h of reperfusion and (Fig. 7)
were associated with mild oedema as shown by histology (Fig. 2).
However, macrophage ablation by clodronate mitigated levels of
circulating TGF-β1 10 h after reperfusion (Fig. 7), (TGF-β1 control:
3625.13 ± 458 vs clodronate: 1683.57 ± 251 pg/µl, P = 0.039).
DISCUSSION
Our study indicates that depletion of macrophages from donor
lung transplants beneﬁcially modulates the inﬂammatory re-
sponse from I/R injury in two ways: (i) cell injury was signiﬁcantly
reduced as shown by less release of LDH and HMGB1 in the circu-
lation and (ii) TNF-α and TGF-β1 were both down-regulated in
plasma at 10 h after reperfusion, reﬂecting a sustained suppression
of inﬂammation in the recipient. In spite of only moderate func-
tional improvement of the transplanted graft itself, our data
suggest that donor macrophages contribute to systemic inﬂamma-
tion and can deteriorate graft outcome after lung I/R.
The presence of macrophages has been described to be of dif-
ferential outcome in lung Tx. On the one hand, alveolar macro-
phages have been implicated as key initiators of acute lung injury,
showing that M depletion protects the lungs from I/R-induced
dysfunction and signiﬁcantly reduces cytokine as well as chemo-
kine production. Furthermore, the presence of M indicated that
protein expression of TNF-α and MCP-1 are positively correlated
with I/R-induced lung injury, and M are a major producer of
TNF-α, MCP-1 and macrophage inﬂammatory proteins (MIP)-2
[8]. These data were corroborated by Naidu et al. [7] showing that
alveolar macrophages are the key early source of multiple proin-
ﬂammatory mediators and that depleting alveolar macrophages is
protective against injury. In contrast, Nakamura et al. [12] found
opposite results showing that the absence of macrophages rather
aggravated I/R injury of the lung as reﬂected by increasing
MIP-2-associated alveolar neutrophil recruitment and airway
mechanical dysfunction. The models of I/R injury that were used
in these studies differed from each other such as arterial perfusion
occlusion only, or clamping the entire hilum thus also occluding
Figure 5: Cell injury is reduced upon macrophage depletion. Organ injury after 10 h of Tx was assessed by circulating LDH and HMGB1 that is released from damaged
cells. Macrophage ablation with clodronate resulted in a signiﬁcant reduction of circulating LDH and a non-signiﬁcant reduction in HMGB1 levels in recipient mice
(P = 0.03 and P = 0.3, respectively).
Figure 6: TNF-α level is reduced upon macrophage depletion during late reper-
fusion. The kinetic expression of the pro-inﬂammatory cytokine TNF-α was
measured in the plasma of recipients at two reperfusion time points (at 3 and
10 h). Recipients receiving an M-depleted organ show a signiﬁcantly reduced
level of circulating TNF-α 10 h after reperfusion.
Figure 7: TGF-β1 level is reduced by donor macrophage depletion during late
reperfusion. Circulating TGF-β1 levels increased after 3 h of reperfusion but
decreased after 10 h of reperfusion, indicating a reduced inﬂammatory re-
sponse upon Tx in M-depleted recipients
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the ventilation. This might be responsible for the heterogeneous
results reported. The advantage of our model of orthotopic single
lung Tx is that all conditions equal the human Tx setting: ventila-
tion as well as perfusion is stopped for a certain period of time
and cold ischaemia time can be provided.
Besides the transcription factor NF-κB, TNF-α is the key cyto-
kine in the early phase of I/R-injury [13, 14], which is also in line
with the data from Zhao et al. [8] and Naidu et al. [7]. Accordingly,
we could show that circulatory levels of TNF-α (10 h after reperfu-
sion) from M-depleted animals were signiﬁcantly decreased upon
reperfusion. In contrast, levels of TNF-α early after reperfusion
(3 h) did not show any differences to controls, suggesting that
other TNF-α-producing cells may play a role in the early phase.
However, at a later stage, macrophages seem to be decisive in the
production of this strong proinﬂammatory cytokine. Much to our sur-
prise, we could not ﬁnd any difference in intragraft levels of TNF-α
(data not shown). Unlike systemically increase levels of TNF-α, we did
not ﬁnd TNF-α to be change within the transplanted graft. This result
might be due to lysed macrophages-derived shedding of antigenic
material which induce a systemic inﬂammatory response in the per-
iphery. The depletion of M not only diminished proinﬂammatory
cytokines and chemokines, it also has an inﬂuence on the recruit-
ment of neutrophils, the latter being responsible for the late-
phase injury [15]. Accordingly, our histology suggested an
improvement of organ architecture, showing less cell inﬁltrates,
including neutrophils. Ross et al. [15] showed in a rabbit model
of vessel ligation that the administration of anti-TNF-α
and anti-IL-1β antibodies before reperfusion blocked neutrophil
chemotaxis and chemokine and cytokine production and was re-
sponsible for less I/R-injury. Antagonizing the effects of TNF-α
with an antibody was also convincingly shown by Khimenko et al.
[16] in an ex vivo-perfused rat lung model of I/R-injury and by
Krishnadasan et al. [17] in an in vivo model of hilum clamping.
Apoptosis is the main mechanism of cell death that occurs
in I/R-injury in both experimental and human lung Tx [13]. In
contrast to necrosis which occurs in ischaemia, apoptosis is
present only after reperfusion and increases rapidly with a peak
around 2 h after reperfusion [18]. In this context, the duration of
cold ischaemia closely correlates with the proportion of apoptosis
and necrosis. A cold ischaemic time up to 12 h is associated rather
with an apoptotic appearance of the graft [19]. In our study, we
employed 8 h of ischaemia in order to induce a marked but not
disastrous injury to the graft. Yet, we could show severe cell damage
by signiﬁcant elevated levels of LDH released into the circulation
at 10 h after reperfusion. Even worse, enhanced release of
HMGB1 (a nuclear factor, released upon necrosis [20]) 10 h after
reperfusion indicated that necrosis rather than apoptosis was
induced during a later time point of reperfusion. Given the fact
that necrosis is associated with signiﬁcant worsened lung function
due to high degree of inﬂammation [21], the reduction in HMGB1
levels due to the absence of M indicates a rather cell-protective
effect.
We were not able to show an effect towards alternatively acti-
vated M of the population resting within the engrafted organ (30%
of non-depleted M). TGF-β1 is known to drive M2 differentiation
from monocytes and can thereby evolve anti-inﬂammatory
effects. But TGF-β1 also mediates acute and chronic lung injury in-
cluding alveolar ﬂooding, increment of endothelial permeability,
oedema and pulmonary ﬁbrosis [22]. After 10 h of reperfusion,
levels of circulating TGF-β1 were reduced in the clodronate-
treated group, while they were increased in the control group. We
concluded from these data that the majority of the depleted
donor macrophages rather belong to the classical M population as
TNF-α levels strikingly declined upon M depletion.
The M depletion method in transplant donors has the potential
for major clinical impact. Fiser et al. [23] successfully depleted
donor M by using gadolinium chloride (GDC) and showed that
reperfusion injury was attenuated at an early time point. However,
the potential application of clodronate is more likely to be used in
the Tx setting, as GDC must be given 24 h in advance to effectively
limit macrophage functionality. In contrast, clodronate induces
macrophage lysis within 6 h of application. Given the time frame
from organ retrieval to implant into the recipient of a maximum of
6 h, it is well imaginable that clodronate can be administered upon
organ harvesting in order to develop its efﬁcacy during this period.
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